About Forkhead box protein P3
Forkhead box protein P3 (FOXP3) is a protein
from Homo sapiens identified by UniProt accession
Q9BZS1, 431 residues long.
MolForge cross-references it against 0 known binders and
1,693 disease associations.
Target properties
| Protein name | Forkhead box protein P3 |
| UniProt accession | Q9BZS1 |
| Gene | FOXP3 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1693)
Diseases linked to this target (Open Targets).
- immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome · score 0.85
- type 1 diabetes mellitus · score 0.55
- hydrops fetalis · score 0.50
- neurodegenerative disease · score 0.45
- azoospermia · score 0.43
- Neurodevelopmental disorder · score 0.34
- Pancytopenia · score 0.34
- anemia · score 0.34
- multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome · score 0.27
- genetic disorder · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BZS1-F1 | alphafold | PREDICTED | 56.73 | — |
Amino-acid sequence (431 residues)
MPNPRPGKPS APSLALGPSP GASPSWRAAP KASDLLGARG PGGTFQGRDL RGGAHASSSS LNPMPPSQLQ LPTLPLVMVA PSGARLGPLP HLQALLQDRP HFMHQLSTVD AHARTPVLQV HPLESPAMIS LTPPTTATGV FSLKARPGLP PGINVASLEW VSREPALLCT FPNPSAPRKD STLSAVPQSS YPLLANGVCK WPGCEKVFEE PEDFLKHCQA DHLLDEKGRA QCLLQREMVQ SLEQQLVLEK EKLSAMQAHL AGKMALTKAS SVASSDKGSC CIVAAGSQGP VVPAWSGPRE APDSLFAVRR HLWGSHGNST FPEFLHNMDY FKFHNMRPPF TYATLIRWAI LEAPEKQRTL NEIYHWFTRM FAFFRNHPAT WKNAIRHNLS LHKCFVRVES EKGAVWTVDE LEFRKKRSQR PSRCSNPTPG P
Explore Forkhead box protein P3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets